News >

Pilot Study Will Test the Combined Power of Watson for Oncology and Cota

Tony Hagen @oncobiz
Published: Friday, Jun 02, 2017

Robert Garrett, co-CEO of Hackensack Meridian Health

Robert Garrett

Hackensack Meridian Health will pilot a study that combines the use of IBM’s Watson for Oncology, which interprets patient data and provides treatment guidance, and Cota, which provides real-world patient data for large cohort analysis and individualized treatment guidance. The goal is to help oncologists make improved evidence- and outcomes-based clinical decisions for their cancer patients and potentially also reduce overall costs of care.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication